M3 muscarinic acetylcholine receptor reactive IL-17 producing t cells promotes development of sjögren’s syndrome like sialadenitis

Modern Rheumatology

Volumn 25, Issue 1, 2015, Pages 158-160

  Iizuka, Mana ^a   Tsuboi, Hiroto ^a   Asashima, Hiromitsu ^a   Hirota, Tomoya ^a   Kondo, Yuya ^a   Matsui, Minoru ^b   Matsumoto, Isao ^a   Sumida, Takayuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b Tokyo Nishi Tokushukai Hospital   (Japan)

Author keywords

B cells; IL 17; M3 muscarinic acetylcholine receptor; Mouse Model; Sj gren s syndrome

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; MUSCARINIC M3 RECEPTOR;

APOPTOSIS; B LYMPHOCYTE ACTIVATION; IMMUNOHISTOCHEMISTRY; NONHUMAN; NOTE; PRIORITY JOURNAL; SALIVARY GLAND; SIALOADENITIS; SJOEGREN SYNDROME; T LYMPHOCYTE; XEROSTOMIA; ANIMAL; GENETICS; METABOLISM; MOUSE; TRANSGENIC MOUSE;

ANIMALS; INTERLEUKIN-17; MICE; MICE, TRANSGENIC; RECEPTOR, MUSCARINIC M3; SIALADENITIS; SJOGREN'S SYNDROME; T-LYMPHOCYTES;

EID: 84983458530     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.3109/14397595.2014.884683     Document Type: Note

References (10)

1. Fox R I, Stern M. Sjogren’s syndrome: mechanisms of pathogenesis involve interaction of immune and neurosecretory systems. Scand J Rheumatol Suppl. 2002; 116: 3-13.
2. Sumida T, Namekawa T, Maeda T, Nishioka K. New T-cell epitope of Ro/SS-A 52 kD protein in labial salivary glands from patients with Sjogren’s syndrome. Lancet. 1996; 348(9042): 1667.
3. Naito Y, Matsumoto I, Wakamatsu E, Goto D, Sugiyama T, Matsumura R, et al. Musucarinic acetylcholine receptor autoantibodies in patient with Sjogren’s syndrome. Ann Rheum Dis. 2005; 64(3): 510-11.
4. Dawson LJ, Stanbury J, Venn N, Hasdimir B, Rogers SN, Smith PM. Antimuscurinic antibodies in primary Sjogren’s syndrome reversibly inhibit the mechanism of fl uid secretion by human submandibular salivary acinar cells. Arthritis Rheum. 2006; 54(4): 1165-73.
5. Matsui M, Motomura D, Karasawa H, Fujikawa T, Jiang J, Komiya Y, et al. Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. Proc Natl Acad Sci USA. 2000; 97(17): 9579-84.
6. Iizuka M, Wakamatsu E, Tsuboi H, Nakamura Y, Hayashi T, Matsui M, et al. Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjogren’s syndrome-like sialoadenitis. J Autoimmun. 2010; 35(4): 383-9.
7. Iizuka M, Tsuboi H, Matsuo N, Kondo Y, Asashima H, Matsui M, et al. The crucial roles of IFN-g in the development of M3 muscarinic acetylcholine receptor induced Sjogren’s syndrome-like sialadenitis. Mod Rheumatol. 2013; 23(3): 614-6.
8. Mitsdoerffer M, Lee Y, Jager A, Kim H J, Korn T, Kolls J K, et al. Proinfl ammatory T helper type 17 cells are eff ective B-cell helpers. Proc Natl Acad Sci USA. 2010; 107(32): 14292-7.
9. Peters A, Pitcher L A, Sullivan J M, Mitsdoerffer M, Acton S E, Franz B, et al. Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity. 2011; 35(6): 986-96.
10. Reksten TR, Jonsson MV, Szyszko EA, Brun JG, Jonsson R, Brokstad KA. Cytokine and autoantibody profiling related to histopathological features in primary Sjogren’s syndrome. Rheumatology (Oxford). 2009; 48(9): 1102-6.